CY2002A - N-Phenyl-N-(4-piperidinyl) amides useful as analgesics - Google Patents
N-Phenyl-N-(4-piperidinyl) amides useful as analgesicsInfo
- Publication number
- CY2002A CY2002A CY200297A CY200297A CY2002A CY 2002 A CY2002 A CY 2002A CY 200297 A CY200297 A CY 200297A CY 200297 A CY200297 A CY 200297A CY 2002 A CY2002 A CY 2002A
- Authority
- CY
- Cyprus
- Prior art keywords
- lower alkyl
- group
- alkoxy
- member selected
- carbonyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31131189A | 1989-02-15 | 1989-02-15 | |
US07/448,497 US5019583A (en) | 1989-02-15 | 1989-12-11 | N-phenyl-N-(4-piperidinyl)amides useful as analgesics |
Publications (1)
Publication Number | Publication Date |
---|---|
CY2002A true CY2002A (en) | 1997-12-05 |
Family
ID=26977841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY200297A CY2002A (en) | 1989-02-15 | 1997-12-05 | N-Phenyl-N-(4-piperidinyl) amides useful as analgesics |
Country Status (22)
Country | Link |
---|---|
US (1) | US5019583A (pt) |
EP (1) | EP0383579B1 (pt) |
JP (1) | JP2895145B2 (pt) |
KR (1) | KR0160979B1 (pt) |
AT (1) | ATE140451T1 (pt) |
AU (1) | AU636330B2 (pt) |
CA (1) | CA2010011C (pt) |
CY (1) | CY2002A (pt) |
CZ (1) | CZ402591A3 (pt) |
DE (2) | DE19675028I2 (pt) |
DK (1) | DK0383579T3 (pt) |
ES (1) | ES2088961T4 (pt) |
GR (1) | GR3020719T3 (pt) |
HK (1) | HK78297A (pt) |
IE (1) | IE77156B1 (pt) |
LU (1) | LU90011I2 (pt) |
MX (1) | MX9203024A (pt) |
NL (1) | NL960030I2 (pt) |
NZ (1) | NZ232542A (pt) |
PT (1) | PT93137B (pt) |
SG (1) | SG47967A1 (pt) |
SK (1) | SK402591A3 (pt) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5214148A (en) * | 1990-12-18 | 1993-05-25 | Glaxo Inc. | Analgesic N-phenyl-N-(3-OR1 -3-ME-4-piperidinyl)amides |
US5130321A (en) * | 1990-12-18 | 1992-07-14 | Glaxo Inc. | Analgesic n-phenyl-n-(3-or 1-3-me-4-piperidinyl)amides |
GB9316863D0 (en) * | 1993-08-13 | 1993-09-29 | Glaxo Group Ltd | Chemical process |
US5466700A (en) * | 1993-08-30 | 1995-11-14 | Glaxo Wellcome Inc. | Anesthetic use of N-phenyl-N-(4-piperidinyl)amides |
US5866591A (en) * | 1996-09-11 | 1999-02-02 | Glaxo Wellcome Inc. | Stable formulations of remifentanil |
DE69831876T2 (de) * | 1997-12-24 | 2006-07-27 | Ortho-Mcneil Pharmaceutical, Inc. | (4)-[aryl(piperidin-4-yl) aminobenzamidderivate die an delta-opioid rezeptor binden |
US6858018B1 (en) * | 1998-09-28 | 2005-02-22 | Vyteris, Inc. | Iontophoretic devices |
US6436959B1 (en) | 1998-12-23 | 2002-08-20 | Ortho-Mcneil Pharmaceutical, Inc. | 4-[aryl(piperidin-4-yl)]aminobenzamides |
JP2003515588A (ja) | 1999-12-06 | 2003-05-07 | マリンクロッド・インコーポレイテッド | アルフェンタニル、スフェンタニルおよびレミフェンタニルの新合成法 |
WO2001068604A2 (en) | 2000-03-14 | 2001-09-20 | Sepracor, Inc. | 3-substituted piperidines comprising urea functionality, and methods of use thereof |
DK1307194T4 (da) | 2000-07-31 | 2011-07-18 | Nycomed Danmark Aps | Fentanylpræparat til nasal administration |
CA2443350A1 (en) | 2001-04-03 | 2002-12-05 | Aryx Therapeutics | Ultrashort-acting opioids for transdermal application |
JP2005516926A (ja) * | 2001-12-17 | 2005-06-09 | アリックス セラピューティクス | 鎮痛薬の送達システム及び使用方法 |
WO2005030722A1 (ja) * | 2003-09-29 | 2005-04-07 | Nippon Chemiphar Co., Ltd. | N-置換-n-(4-ピペリジニル)アミド誘導体 |
WO2005123679A2 (en) * | 2004-06-18 | 2005-12-29 | Neurosearch A/S | Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
EP1795526A4 (en) * | 2004-09-14 | 2010-10-13 | Nippon Chemiphar Co | N-SUBSTITUTED N- (4-PIPERIDINYL) AMIDE DERIVATIVE |
EP1966140A1 (en) * | 2005-11-17 | 2008-09-10 | Mallinckrodt, Inc. | Process for synthesizing remifentanil |
CN101374812A (zh) * | 2006-01-24 | 2009-02-25 | 马林克罗特公司 | 合成瑞芬太尼的方法 |
JP2009525329A (ja) * | 2006-02-03 | 2009-07-09 | マリンクロッド・インコーポレイテッド | レミフェンタニル塩酸塩の結晶形 |
EP1867635A1 (en) * | 2006-06-15 | 2007-12-19 | Kern Pharma, S.L. | Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for their preparation |
KR20170091770A (ko) * | 2006-07-10 | 2017-08-09 | 파이온 유케이 리미티드 | 속효형 벤조디아제핀 염 및 이의 중합체 형태 |
GB0613693D0 (en) * | 2006-07-10 | 2006-08-16 | Cenes Ltd | Benzodiazepine salts (3) |
US20100099880A1 (en) * | 2006-10-05 | 2010-04-22 | Brian Cheng | Alternate Process for Remifentanil Preparation |
US20100048908A1 (en) * | 2006-11-29 | 2010-02-25 | Brian Kai-Ming Cheng | Process for Remifentanil Synthesis |
JP5580287B2 (ja) * | 2008-03-31 | 2014-08-27 | ザ ジェネラル ホスピタル コーポレイション | 改善された薬物速度論的および薬力学的特性を有するエトミデート類似体 |
US20110144346A1 (en) * | 2008-07-03 | 2011-06-16 | Cilag Ag | Method for producing n-phenyl-n-(4-piperidinyl) amide salts |
WO2010053944A1 (en) * | 2008-11-04 | 2010-05-14 | Cambrex Charles City, Inc. | Improved method of making piperidine derivatives |
CA2767112C (en) | 2009-07-10 | 2018-06-19 | The General Hospital Corporation | Etomidate analogues that do not inhibit adrenocortical steroid synthesis |
EP2450039A1 (en) | 2010-11-08 | 2012-05-09 | PAION UK Ltd. | Dosing regimen for sedation with CNS 7056 (Remimazolam) |
ES2617536T3 (es) | 2012-01-13 | 2017-06-19 | The General Hospital Corporation | Compuestos anestésicos y métodos relacionados de uso |
JP6309957B2 (ja) | 2012-10-08 | 2018-04-11 | オークランド ユニサービシーズ リミティド | ケタミン誘導体 |
AR094963A1 (es) | 2013-03-04 | 2015-09-09 | Ono Pharmaceutical Co | Reacción de oxidación excelente en el índice de conversión |
CN103728403B (zh) * | 2013-08-30 | 2015-10-07 | 宜昌人福药业有限责任公司 | 一种盐酸瑞芬太尼原料药中有关物质的检测方法 |
ES2699636T3 (es) | 2016-01-29 | 2019-02-12 | Bioka S R O | Nuevo procedimiento para la preparación de derivados de N-fenil-N-(4-piperidinil) amida, como remifentanilo y carfentanilo |
SI3643704T1 (sl) | 2018-10-26 | 2021-04-30 | Hameln Pharma Gmbh | Novi intermediati za pripravo remifentanil hidroklorida |
GB202010168D0 (en) | 2020-07-02 | 2020-08-19 | Johnson Matthey Plc | Process for preparing remifentanil hydrochloride |
CN114262320A (zh) * | 2021-12-28 | 2022-04-01 | 宜昌人福药业有限责任公司 | 一种利用连续流微通道反应器制备苯胺基哌啶类药物的合成方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE623427A (pt) * | 1961-10-10 | |||
US3655675A (en) * | 1968-09-09 | 1972-04-11 | Sterling Drug Inc | N-(n-heteryl)-acylanilides |
US3998834A (en) * | 1975-03-14 | 1976-12-21 | Janssen Pharmaceutica N.V. | N-(4-piperidinyl)-n-phenylamides and -carbamates |
US4179569A (en) * | 1975-03-14 | 1979-12-18 | Janssen Pharmaceutica N.V. | N-(4-piperidinyl)-N-phenylamides |
US4167574A (en) * | 1978-03-13 | 1979-09-11 | Janssen Pharmaceutica, N.V. | N-phenyl-N-(4-piperidinyl)amides |
US4584303A (en) * | 1984-04-09 | 1986-04-22 | The Boc Group, Inc. | N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds |
US4801721A (en) * | 1984-08-16 | 1989-01-31 | Ryan James W | Stereospecific synthesis of carboxyalkyl peptides |
CA1317940C (en) * | 1987-09-25 | 1993-05-18 | Georges H. P. Van Daele | Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides |
-
1989
- 1989-12-11 US US07/448,497 patent/US5019583A/en not_active Expired - Lifetime
-
1990
- 1990-02-14 CA CA002010011A patent/CA2010011C/en not_active Expired - Fee Related
- 1990-02-14 DE DE1996175028 patent/DE19675028I2/de active Active
- 1990-02-14 SG SG1996005735A patent/SG47967A1/en unknown
- 1990-02-14 AU AU49731/90A patent/AU636330B2/en not_active Expired
- 1990-02-14 ES ES90301586T patent/ES2088961T4/es not_active Expired - Lifetime
- 1990-02-14 NZ NZ232542A patent/NZ232542A/en unknown
- 1990-02-14 DE DE69027794T patent/DE69027794T2/de not_active Expired - Lifetime
- 1990-02-14 IE IE53290A patent/IE77156B1/en not_active IP Right Cessation
- 1990-02-14 PT PT93137A patent/PT93137B/pt not_active IP Right Cessation
- 1990-02-14 JP JP2031680A patent/JP2895145B2/ja not_active Expired - Lifetime
- 1990-02-14 EP EP90301586A patent/EP0383579B1/en not_active Expired - Lifetime
- 1990-02-14 KR KR1019900001796A patent/KR0160979B1/ko not_active IP Right Cessation
- 1990-02-14 DK DK90301586.5T patent/DK0383579T3/da active
- 1990-02-14 AT AT90301586T patent/ATE140451T1/de active
-
1991
- 1991-12-23 SK SK4025-91A patent/SK402591A3/sk unknown
- 1991-12-23 CZ CS914025A patent/CZ402591A3/cs unknown
-
1992
- 1992-06-19 MX MX9203024A patent/MX9203024A/es unknown
-
1996
- 1996-08-02 GR GR960402083T patent/GR3020719T3/el unknown
- 1996-11-21 NL NL960030C patent/NL960030I2/nl unknown
-
1997
- 1997-01-24 LU LU90011C patent/LU90011I2/fr unknown
- 1997-06-12 HK HK78297A patent/HK78297A/xx not_active IP Right Cessation
- 1997-12-05 CY CY200297A patent/CY2002A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2010011A1 (en) | 1990-08-15 |
IE77156B1 (en) | 1997-12-03 |
AU636330B2 (en) | 1993-04-29 |
AU4973190A (en) | 1990-08-23 |
HK78297A (en) | 1997-06-20 |
KR900012906A (ko) | 1990-09-03 |
GR3020719T3 (en) | 1996-11-30 |
LU90011I2 (fr) | 1997-03-11 |
DK0383579T3 (da) | 1996-10-14 |
ES2088961T3 (es) | 1996-10-01 |
NL960030I2 (nl) | 1997-05-01 |
MX9203024A (es) | 1992-07-01 |
CZ402591A3 (en) | 1993-04-14 |
JP2895145B2 (ja) | 1999-05-24 |
KR0160979B1 (ko) | 1998-12-01 |
CA2010011C (en) | 1997-12-02 |
NZ232542A (en) | 1992-06-25 |
US5019583A (en) | 1991-05-28 |
PT93137A (pt) | 1990-08-31 |
NL960030I1 (nl) | 1997-02-03 |
EP0383579B1 (en) | 1996-07-17 |
ES2088961T4 (es) | 1996-12-01 |
PT93137B (pt) | 1996-02-29 |
IE900532L (en) | 1990-08-15 |
DE69027794D1 (de) | 1996-08-22 |
EP0383579A1 (en) | 1990-08-22 |
DE19675028I2 (de) | 2002-11-07 |
SK402591A3 (en) | 2000-09-12 |
ATE140451T1 (de) | 1996-08-15 |
SG47967A1 (en) | 1998-04-17 |
DE69027794T2 (de) | 1997-01-02 |
JPH02300167A (ja) | 1990-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU636330B2 (en) | N-phenyl-n-(4-piperidinyl)amides useful as analgesics | |
EP0150787A3 (en) | Compound having antibronchopneumopathic activity, process for its preparation and pharmaceutical compositions containing it | |
BR9912494A (pt) | Derivado de di ou trifluorometanossulfonil anilida, processo para a sua produção e herbicida contendo o referido derivado como ingrediente ativo | |
DE19575041I2 (de) | Substituierte Acyl-Derivate von 1, 2, 3, 4-Tetrahydro-6, 7-dimethoxy-3-isoquinolin-Carbonsaeure | |
HUT50100A (en) | Process for producing tetraline-esters of phenols or benzoic acids and pharmaceutical compositions containing them | |
PT94297A (pt) | Processo para a preparacao de n-hetero-aril-purin-6-aminas e de composicoes farmaceuticas que as contem | |
DK26289D0 (da) | Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia | |
PT90725A (pt) | Processo para a preparacao de novos compostos cefem | |
DE69910121D1 (de) | Piperidone als Tachykinin-Hemmer | |
HUT50337A (en) | Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds | |
HU9302395D0 (en) | Method for producing 4-/(benzothiazolyl)-methyl-amino/-alpha-/(3,4-difluorine-phenoxi)-methyl/-1-piperidine-ethanol | |
DK0427518T3 (da) | NMDA-blokerende forbindelser, farmaceutiske præparater, deres fremstilling og anvendelse | |
DK0494604T3 (da) | 1-Piperazinyl-2-butener og -2-butyner, mellemprodukter derfor, en fremgangsmåde til fremstilling deraf og deres anvendelse | |
GR3005904T3 (pt) | ||
MY136018A (en) | Di - or trifluoromethanesulfonyl anilide derivative, process for production thereof, and herbicide containing said derivative as active ingredient |